E
Galmed Pharmaceuticals Ltd. GLMD
$1.55 -$0.08-4.91% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 06/30/2024 06/30/2024 03/31/2024
Net Income 13.41% -59.18% 29.76% 29.76% 30.33%
Total Depreciation and Amortization -- -100.00% 722.22% 722.22% 12.50%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -49.35% 1,435.29% 700.00% 700.00% -5.52%
Change in Net Operating Assets 80.36% -159.11% -145.54% -145.54% -1,894.44%
Cash from Operations 36.23% -119.27% 25.60% 25.60% -7.96%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -153.47% -255.73% 97.45% 97.45% -68.02%
Cash from Investing -153.47% -255.73% 97.45% 97.45% -68.02%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 108.30% -467.13% 156.65% 156.65% -306.40%